An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The treatment of chronic bradycardia, one of the cardiovascular diseases, remains an
essential unsolved issue. The objective of this project is to speed up a new drug CARDIX-101
clinical Phase 1IA trial for the treatment of chronic bradycardia and to solve an unmet
medical need.
To date, there is no regulatory approved drug of this type available in the U.S or the world.
If the new drug CARDIX-101 demonstrated a significant positive effect on chronic bradycardia,
it should have a sizeable demand and solve an unmet medical need.